The results of our study aligns with prior work demonstrating an association between high survivin expression and aggressive breast tumor features including hormone receptor negativity, higher stage, larger size, and non-Luminal A subtype [20–23, 40], all of which remained significantly associated, independent of estrogen receptor status. This evidence concerns the gene ESR1 and breast neoplasm.